Study backs use of new heart risk tool

A cardiovascular risk assessment tool specific to the UK population has proved its worth and should be adopted across the country, say its developers.

Dr Rubin Minhas
Dr Rubin Minhas
The QRISK algorithm, which has been developed from UK general practice data, has shown its worth in an independent validation study of more than a million UK patients.

Compared with Framingham, the tool developed in the US in the 1970s and still used in the UK, QRISK was better at classifying patients into high or low categories of cardiovascular risk.

Framingham over predicted risk by 23 per cent and QRISK under predicted by 12 per cent.

This could be important when deciding if people have a 20 per cent risk of a cardiovascular event in 10 years, thereby making them eligible for statin therapy.

Apart from being developed in the UK, QRISK also differs from Framingham by taking deprivation into account.

Depending on a pending NICE guideline on lipid modification, QRISK could be used instead of Framingham across the UK to assess cardiovascular risk.

Lead researcher Dr Peter Brindle, a GP and research and development lead for Bristol PCT, said: ‘NICE are deliberating on it now.’

Dr Brindle is a member of the guideline development group at NICE, which is expected to publish the guideline in January.

‘Whatever NICE do I suspect there will be a large number of people willing to use QRISk because of the problems with health inequalities in the UK,’ he said.

‘Continuing to use Framingham could exacerbate health inequalities.’

Kent GP Dr Rubin Minhas, CHD lead for Medway PCT, said: ‘Framingham now looks like a more inaccurate risk tool and QRISK could prevent hundreds of thousands if not millions of people being unnecessarily treated.’

However, independent evaluation by NICE is needed, he added.

But Professor Mike Kirby, member of the Primary Care Cardiovascular Society, said: ‘I don’t think it matters that much as long as people estimate risk. You’re just really drawing a line in the sand.’

Nevertheless, he added: ‘I think it is a good idea to use a UK cohort. It will depend on NICE.’

rachel.liddle@haymarket.com

Heart 2007 Online

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Proportion of NHS GPs trained in EEA stabilises despite Brexit uncertainty

Proportion of NHS GPs trained in EEA stabilises despite Brexit uncertainty

The proportion of NHS GPs trained in the EEA has stabilised after a steady decline...

GPs split on calls to suspend appraisal for duration of pandemic

GPs split on calls to suspend appraisal for duration of pandemic

Senior GPs are divided over calls for appraisal to be halted for the rest of the...

GP fears rising over covert recording of consultations in pandemic

GP fears rising over covert recording of consultations in pandemic

Fears over patients covertly recording consultations have increased among GPs since...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Vaccination of care home residents against COVID-19 will start on 14 December in...

How will the COVID-19 vaccination programme get underway?

How will the COVID-19 vaccination programme get underway?

Following the MHRA's approval of Pfizer/BioNTech's COVID-19 jab the government has...